First-of-its-Kind Implantable CGM Approved by FDA
Using first-of-its-kind technology, the Eversense Continuous Glucose Monitoring (CGM) system can be implanted in the arm for up to three months…
Debra Filcman
Filcman is a Chicago-based freelance journalist specializing in healthcare. She has previously worked newsrooms, agencies and universities in Massachusetts and Illinois.
Debra Filcman on social media
